AnaCardio AB announced that it has received SEK 150 million in funding from Industrifonden, Karolinska Development AB, Flerie Invest AB, and other investors

AnaCardio AB announced that it has received SEK 150 million in a round of funding led by Flerie Invest AB, and Industrifonden on September 7, 2022. The transaction also included participation from 3B Health Ventures, returning investors Karolinska Development AB , and individual investors Fredrik and Ann-Helene Ljungström.